Gyne-Chord
NDC 64578-0063, Homeopathic Liquid, liquid, from Energetix Corporation.
- Product NDC
- 64578-0063
- Status
- Listed
- Labeler
- Energetix Corporation
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0063 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANGELICA SINENSIS ROOT8 [hp_X]/59.1mL
- GOLD TRICHLORIDE15 [hp_X]/59.1mL
- BORIC ACID12 [hp_X]/59.1mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE15 [hp_X]/59.1mL
- CANDIDA ALBICANS12 [hp_X]/59.1mL
- BLACK COHOSH6 [hp_X]/59.1mL
- ESTRONE7 [hp_C]/59.1mL
- SUS SCROFA ADRENAL GLAND9 [hp_X]/59.1mL
- CHAMAELIRIUM LUTEUM ROOT12 [hp_X]/59.1mL
- GOLDENSEAL12 [hp_X]/59.1mL
- WOOD CREOSOTE15 [hp_X]/59.1mL
- MERCURIUS SOLUBILIS12 [hp_X]/59.1mL
- SODIUM SULFATE12 [hp_X]/59.1mL
- SUS SCROFA OVARY9 [hp_X]/59.1mL
- PULSATILLA VULGARIS12 [hp_X]/59.1mL
- SEPIA OFFICINALIS JUICE12 [hp_X]/59.1mL
- DELPHINIUM STAPHISAGRIA SEED12 [hp_X]/59.1mL
- THUJA OCCIDENTALIS LEAFY TWIG12 [hp_X]/59.1mL
- THYROID, UNSPECIFIED9 [hp_X]/59.1mL
- ZINC GLUCONATE8 [hp_X]/59.1mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64578-0063-1 | 64578006301 | 59.1 mL in 1 BOTTLE, DROPPER (64578-0063-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 64578-0063 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0063 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64578-0063. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.